Camilla Muccini

1.3k total citations
47 papers, 239 citations indexed

About

Camilla Muccini is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Camilla Muccini has authored 47 papers receiving a total of 239 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Infectious Diseases, 26 papers in Virology and 13 papers in Emergency Medicine. Recurrent topics in Camilla Muccini's work include HIV/AIDS drug development and treatment (25 papers), HIV Research and Treatment (24 papers) and HIV/AIDS Research and Interventions (20 papers). Camilla Muccini is often cited by papers focused on HIV/AIDS drug development and treatment (25 papers), HIV Research and Treatment (24 papers) and HIV/AIDS Research and Interventions (20 papers). Camilla Muccini collaborates with scholars based in Italy, United States and Netherlands. Camilla Muccini's co-authors include Antonella Castagna, Vincenzo Spagnuolo, Laura Galli, Nicola Gianotti, Adriano Lazzarin, Simona Bossolasco, Silvia Nozza, Diana Canetti, Jintanat Ananworanich and Martina Ranzenigo and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Camilla Muccini

37 papers receiving 239 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Camilla Muccini Italy 9 164 118 71 42 32 47 239
Stacey Chapman United States 9 147 0.9× 98 0.8× 176 2.5× 65 1.5× 45 1.4× 14 329
Ali Elgalib Oman 11 170 1.0× 65 0.6× 128 1.8× 110 2.6× 29 0.9× 31 281
Maria Christine Thurnheer Switzerland 8 150 0.9× 60 0.5× 142 2.0× 66 1.6× 27 0.8× 16 304
Shabir Lakhi United States 8 191 1.2× 119 1.0× 77 1.1× 15 0.4× 13 0.4× 14 232
Gaby Knecht Germany 9 140 0.9× 71 0.6× 108 1.5× 31 0.7× 7 0.2× 19 224
Margherita Bracchi United Kingdom 7 187 1.1× 126 1.1× 98 1.4× 75 1.8× 7 0.2× 25 268
Rossana Ditangco Philippines 10 257 1.6× 160 1.4× 110 1.5× 61 1.5× 4 0.1× 16 300
Judith Mabuta Botswana 6 226 1.4× 63 0.5× 56 0.8× 85 2.0× 11 0.3× 16 376
Kathrin van Bremen Germany 7 92 0.6× 76 0.6× 145 2.0× 60 1.4× 5 0.2× 17 244
Οlga Tsachouridou Greece 10 137 0.8× 47 0.4× 130 1.8× 38 0.9× 11 0.3× 47 242

Countries citing papers authored by Camilla Muccini

Since Specialization
Citations

This map shows the geographic impact of Camilla Muccini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Camilla Muccini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Camilla Muccini more than expected).

Fields of papers citing papers by Camilla Muccini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Camilla Muccini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Camilla Muccini. The network helps show where Camilla Muccini may publish in the future.

Co-authorship network of co-authors of Camilla Muccini

This figure shows the co-authorship network connecting the top 25 collaborators of Camilla Muccini. A scholar is included among the top collaborators of Camilla Muccini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Camilla Muccini. Camilla Muccini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Raccagni, Angelo Roberto, et al.. (2025). Routine HIV RNA Testing During Injectable Cabotegravir and Oral Preexposure Prophylaxis Use. Clinical Infectious Diseases.
2.
3.
Raccagni, Angelo Roberto, Elena Bruzzesi, Caterina Candela, et al.. (2025). Antimicrobial use for the treatment of bacterial sexually transmitted infections among doxycycline post-exposure prophylaxis (DoxyPEP) users in Milan, Italy. Journal of Antimicrobial Chemotherapy. 80(9). 2484–2486.
4.
Galli, Laura, et al.. (2024). Outcomes after a virological failure to first-line second-generation INSTI-based therapy in a real-life setting. Journal of Antimicrobial Chemotherapy. 80(2). 405–408.
5.
Rossotti, Roberto, Alessandro Tavelli, Anna De Bona, et al.. (2024). Do we Still Need Eligibility Criteria to Recommend PrEP? Impact of National Prescribing Requirements on Retention in Care and Sexually Transmitted Infections Acquisition. AIDS and Behavior. 28(7). 2258–2263. 2 indexed citations
6.
Muccini, Camilla, Suteeraporn Pinyakorn, Eugène Kroon, et al.. (2024). Chemsex and rising substance use linked to sexually transmitted infections among men who have sex with men living with HIV in Bangkok, Thailand. IJID Regions. 13. 100465–100465.
7.
Gagliardini, Roberta, Alessandro Tavelli, Giuseppe Lapadula, et al.. (2024). OC-10 Effectiveness of long-acting art with cabotegravir/rilpivirine in the icona cohort. A8–A9.
8.
Scheerder, Marie‐Angélique De, Sophie Degroote, Maja Kiselinova, et al.. (2024). In-depth Analysis of the HIV Reservoir Confirms Effectiveness and Safety of Dolutegravir/Lamivudine in a Phase 4 Randomized Controlled Switch Trial (RUMBA). The Journal of Infectious Diseases. 231(1). e91–e100. 2 indexed citations
9.
Muccini, Camilla, et al.. (2024). Cardiometabolic complications in children and adolescents with HIV on antiretroviral therapy. Expert Opinion on Drug Metabolism & Toxicology. 20(9). 893–905. 1 indexed citations
10.
Canetti, Diana, Laura Galli, Silvia Nozza, et al.. (2023). Bictegravir/Emtricitabine/Tenofovir Alafenamide Treatment: Efficacy and Tolerability in Clinical Practice. Drug Design Development and Therapy. Volume 17. 3697–3706. 2 indexed citations
11.
Rossotti, Roberto, Massimo Cernuschi, Federico D’Amico, et al.. (2023). Detection of Asymptomatic Mpox Carriers among High-Ri Men Who Have Sex with Men: A Prospective Analysis. Pathogens. 12(6). 798–798. 5 indexed citations
12.
Muccini, Camilla & Antonella Castagna. (2023). A four-drug combination oral tablet of darunavir, cobicistat, emtricitabine, and tenofovir alafenamide for the treatment of HIV-1 infection in adults. Expert Review of Anti-infective Therapy. 21(11). 1167–1176. 1 indexed citations
13.
Messina, Emanuela, Angelo Roberto Raccagni, Nicola Clementi, et al.. (2023). A case of breakthrough mpox infection in an individual non-responder to MVA-BN vaccination. The Lancet Infectious Diseases. 24(1). e11–e12. 1 indexed citations
14.
Galli, Laura, Camilla Muccini, Andrea Poli, et al.. (2023). Increasing incidence and prevalence of metabolic syndrome in people living with HIV during the COVID-19 pandemic. Frontiers in Medicine. 10. 1220631–1220631. 1 indexed citations
15.
Galli, Laura, Andrea Poli, Camilla Muccini, et al.. (2023). Treatment success of rescue regimens after dual therapy failure in people living with HIV in a real-life setting. International Journal of Antimicrobial Agents. 62(2). 106897–106897. 1 indexed citations
16.
Muccini, Camilla, Diana Canetti, Antonella Castagna, & Vincenzo Spagnuolo. (2022). Efficacy and Safety Profile of Fostemsavir for the Treatment of People with Human Immunodeficiency Virus-1 (HIV-1): Current Evidence and Place in Therapy. SHILAP Revista de lepidopterología. 19 indexed citations
17.
Muccini, Camilla, Suteeraporn Pinyakorn, Sunee Sirivichayakul, et al.. (2021). Brief Report: Prevalence Trend of Transmitted Drug Resistance in a Prospective Cohort of Thai People With Acute HIV Infection. JAIDS Journal of Acquired Immune Deficiency Syndromes. 87(5). 1173–1177. 2 indexed citations
18.
Castagna, Antonella, Camilla Muccini, Laura Galli, et al.. (2019). Analytical treatment interruption in chronic HIV-1 infection: time and magnitude of viral rebound in adults with 10 years of undetectable viral load and low HIV-DNA (APACHE study). Journal of Antimicrobial Chemotherapy. 74(7). 2039–2046. 25 indexed citations
19.
Muccini, Camilla, Trevor A. Crowell, Eugène Kroon, et al.. (2019). Leveraging early HIV diagnosis and treatment in Thailand to conduct HIV cure research. AIDS Research and Therapy. 16(1). 25–25. 30 indexed citations
20.
Muccini, Camilla, Laura Galli, Andrea Poli, et al.. (2018). Brief Report: Hyperbilirubinemia Is Associated With a Decreased Risk of Carotid Atherosclerosis in HIV-Infected Patients on Virological Suppression. JAIDS Journal of Acquired Immune Deficiency Syndromes. 79(5). 617–623. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stacey Chapman Breakdown of academic impact, for papers by Ali Elgalib Breakdown of academic impact, for papers by Maria Christine Thurnheer Breakdown of academic impact, for papers by Shabir Lakhi Breakdown of academic impact, for papers by Gaby Knecht Breakdown of academic impact, for papers by Margherita Bracchi Breakdown of academic impact, for papers by Rossana Ditangco Breakdown of academic impact, for papers by Judith Mabuta Breakdown of academic impact, for papers by Kathrin van Bremen Breakdown of academic impact, for papers by Οlga Tsachouridou
Rankless by CCL
2026